Clinical Trial Update: Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating combination chemotherapy and bevacizumab with the NovoTTF-100L(P) system for colorectal cancer with liver metastases; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Malignant Neoplasm, Colorectal Carcinoma Metastatic in the Liver | Phase 1 | Status: ACTIVE_NOT_RECRUITING